Review
[Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination]
[Article in
Italian]
Affiliations
- PMID: 7789083
Item in Clipboard
Review
[Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination]
[Article in
Italian]
Clin Ter.
1995 Mar.
Abstract
The authors provide evidence for the efficacy of the buflomedil-pentoxifylline-defibrotide combination for treatment of lower limb chronic obstructive arterial disease, Fontain stage II. Improvement of walking autonomy obtained with these agents ranged from 50 to 100% in 29 of 36 patients (relative frequency = 0.80).
Similar articles
-
[Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].Clin Ter. 1986 Jun 30;117(6):499-509. Clin Ter. 1986. PMID: 3527536 Italian. No abstract available.
-
[Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].Minerva Cardioangiol. 1986 Nov;34(11):745-9. Minerva Cardioangiol. 1986. PMID: 2949163 Italian. No abstract available.
-
[Clinical experience in patients with chronic peripheral obliterating arteriopathy: defibrotide versus definite molecular weight heparan sulfate (MW 7500-15000 dalton)].Minerva Cardioangiol. 1996 Jan-Feb;44(1-2):33-7. Minerva Cardioangiol. 1996. PMID: 8767620 Clinical Trial. Italian.
-
Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review.Int Angiol. 1992 Jul-Sep;11(3):204-10. Int Angiol. 1992. PMID: 1460355 Review.
-
Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.J Med. 1988;19(2):89-107. J Med. 1988. PMID: 3049876 Review.